Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treatment Change in Patients with Her2-Positive Advanced Breast Cancer in Colombia

BACKGROUND: Breast cancer is highly prevalent worldwide and leads to high health-care costs. HER2-positive subtype represents 30% of all breast cancers and is associated with a poor prognosis. Patients treated with anti-HER2 therapies frequently develop resistance and require pharmacological treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Calderón, Diana, Pedraza, Adriana, Mancera Urrego, Catalina, Mejía-Mejía, Aurelio, Montealegre-Páez, Ana Lorena, Perdomo, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025648/
https://www.ncbi.nlm.nih.gov/pubmed/32104023
http://dx.doi.org/10.2147/CEOR.S220726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025648/
https://www.ncbi.nlm.nih.gov/pubmed/32104023
http://dx.doi.org/10.2147/CEOR.S220726

Ejemplares similares